FIND_THE_RIGHTJOB.
JOB_REQUIREMENTS
Hires in
Not specified
Employment Type
Not specified
Company Location
Not specified
Salary
Not specified
Sionna Therapeutics is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for CF by developing novel medicines that normalize the function of the CFTR protein. Sionna’s goal is to deliver differentiated medicines for people living with CF that can restore their CFTR function to as close to normal as possible by directly stabilizing CFTR’s nucleotide-binding domain 1 (NBD1), which the company believes is central to potentially unlocking meaningful improvements in clinical outcomes and quality of life for people with CF. Leveraging over a decade of the co-founders’ extensive research on NBD1, the company is advancing a pipeline of novel small molecules engineered to correct the defects caused by the F508del genetic mutation, which resides in NBD1. Sionna is also developing a portfolio of complementary CFTR modulators that are designed to work synergistically with its NBD1 stabilizers to improve CFTR function.
The Vice President, Corporate Communications will be responsible for shaping, leading, and executing the company’s communications strategy to support Sionna’s corporate vision, scientific progress, and business objectives. This role will lead external and internal communications, including media relations, employee communications, and corporate positioning. Reporting to the CFO, this role will serve as strategic leader on communications matters, ensuring alignment across key audiences including employees, investors, media, patients, partners, and the broader scientific community.
Similar jobs
Amazon.com
Seattle, United States
6 days ago
Amazon.com
Seattle, United States
6 days ago
Amazon.com
Arlington, United States
6 days ago
Amazon.com
Seattle, United States
6 days ago
West Virginia University
Morgantown, United States
6 days ago
© 2025 Qureos. All rights reserved.